Esperion Therapeutics, Inc

$1.12+$0.07  (6.67%)
EPS
-0.28
Market cap
$221.93M
Start your journey to financial independence ✨
Snowball will help you to track your portfolio, plan deposits to your brokerage account and increase passive income
Start

Frequently asked questions

What sector does Esperion Therapeutics, Inc (ESPR) operate in?

Esperion Therapeutics, Inc belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Esperion Therapeutics, Inc (ESPR) current stock price?

As of the latest data, Esperion Therapeutics, Inc stock price is $1.12, with a previous close of $1.05. Esperion Therapeutics, Inc gained $0.07 in the last trading session, representing a 6.67% increase.

What is Esperion Therapeutics, Inc (ESPR) current market capitalization?

Esperion Therapeutics, Inc market cap is approximately 221.93 million.

What is Esperion Therapeutics, Inc (ESPR) Earnings Per Share (EPS)?

The trailing EPS is -$0.28, and the forward EPS is -$0.48.

What is Esperion Therapeutics, Inc (ESPR) EBITDA?

Esperion Therapeutics, Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -4.87 million.

Does Esperion Therapeutics, Inc (ESPR) pay dividends?

No. Esperion Therapeutics, Inc does not pay a dividend.

How did Esperion Therapeutics, Inc (ESPR) perform in its most recent earnings report?

In the last report (March 31, 2025), Esperion Therapeutics, Inc posted an EPS surprise of 35.68% and a revenue surprise of -78.72%.